| 1 |
33070465 | AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells. | 2021 Jan |
1 |
| 2 |
28143387 | Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors. | 2017 |
2 |
| 3 |
27748288 | Dual transcripts of BCR-ABL & different polymorphisms in chronic myeloid leukaemia patients. | 2016 May |
1 |
| 4 |
24364873 | Uptake of imatinib-loaded polyelectrolyte complexes by BCR-ABL(+) cells: a long-acting drug-delivery strategy for targeting oncoprotein activity. | 2014 Jul |
1 |
| 5 |
21251937 | Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. | 2011 Sep |
1 |
| 6 |
19571508 | [Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR]. | 2009 Jun |
2 |
| 7 |
16831266 | [Effect and possible mechanism of HnRNP E2 decoy RNA on proliferation of K562 leukemia cells]. | 2006 Jul |
1 |
| 8 |
15087031 | [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia]. | 2004 Apr |
2 |
| 9 |
15236194 | A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient. | 2004 Jul |
1 |